159 related articles for article (PubMed ID: 10365673)
1. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
2. A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?
Persoon AC; Jager PL; Sluiter WJ; Plukker JT; Wolffenbuttel BH; Links TP
PLoS One; 2007 Aug; 2(8):e816. PubMed ID: 17726546
[TBL] [Abstract][Full Text] [Related]
3. Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA).
Petrovic I; LoPresti J; Fatemi S; Gianoukakis A; Burman K; Gomez-Lima CJ; Nguyen CT; Spencer CA
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38686504
[TBL] [Abstract][Full Text] [Related]
4. Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease.
Sa R; Yang T; Zhang Z; Guan F
Oncologist; 2024 Jan; 29(1):e68-e80. PubMed ID: 37669005
[TBL] [Abstract][Full Text] [Related]
5. Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases.
Aydogdu YF; Emreol U; Emre G; Buyukkasap C; Akin M
Sisli Etfal Hastan Tip Bul; 2023; 57(2):257-262. PubMed ID: 37899801
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer.
Giovanella L; D'Aurizio F; Petranović Ovčariček P; Görges R
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38730992
[TBL] [Abstract][Full Text] [Related]
7. Clinical Efficacy of Levothyroxine Sodium plus I 131 in the Treatment of Patients with Thyroidectomy and Its Effect on the Levels of Thyroglobulin and Thyrotropin.
Pang YL; Wang YP; Cheng K
Evid Based Complement Alternat Med; 2022; 2022():9557061. PubMed ID: 35958920
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma.
Oh JR; Ahn BC; Jeong SY; Lee SW; Lee J
Nucl Med Mol Imaging; 2015 Sep; 49(3):174-81. PubMed ID: 26279690
[TBL] [Abstract][Full Text] [Related]
9. Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery.
Shuai JH; Leng ZF; Wang P; Ji YC
World J Clin Cases; 2023 Sep; 11(27):6407-6414. PubMed ID: 37900235
[TBL] [Abstract][Full Text] [Related]
10. Challenges and current advances in the methodology of thyroglobulin measurements.
Đorić I; Šelemetjev S
Bioanalysis; 2024 Jan; 16(1):49-60. PubMed ID: 37991211
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy.
Gigliotti BJ; Jasim S
Endocrine; 2024 Feb; 83(2):251-258. PubMed ID: 37824045
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of thyroglobulin: not only thyroid cancer.
Berlińska A; Świątkowska-Stodulska R
Endocrine; 2024 Jan; ():. PubMed ID: 38182855
[TBL] [Abstract][Full Text] [Related]
13. A distributable LC-MS/MS method for the measurement of serum thyroglobulin.
Shi J; Phipps WS; Owusu BY; Henderson CM; Laha TJ; Becker JO; Razavi M; Emrick MA; Hoofnagle AN
J Mass Spectrom Adv Clin Lab; 2022 Nov; 26():28-33. PubMed ID: 36388059
[TBL] [Abstract][Full Text] [Related]
14. Value of circulating neutrophil elastase for detecting recurrence of differentiated thyroid cancer.
Lee H; Kim TS; Gu JY; Yu MR; Lee SE; Kim ES; Kim HK
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37909732
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Thyrotropin Serum Concentrations and Thyroid Carcinoma.
Zhang X; Tian L; Teng D; Teng W
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894384
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as Biomarkers in Thyroid Carcinoma.
Celano M; Rosignolo F; Maggisano V; Pecce V; Iannone M; Russo D; Bulotta S
Int J Genomics; 2017; 2017():6496570. PubMed ID: 29038786
[TBL] [Abstract][Full Text] [Related]
17. TSH Suppression in Differentiated Thyroid Cancer Patients. Still More Questions than Answers after 30 Years.
Biondi B
Thyroid; 2024 May; ():. PubMed ID: 38742990
[No Abstract] [Full Text] [Related]
18. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
[TBL] [Abstract][Full Text] [Related]
19. Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer.
Spencer C; Fatemi S; Singer P; Nicoloff J; Lopresti J
Thyroid; 2010 Jun; 20(6):587-95. PubMed ID: 20470203
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
